Tesamorelin Peptide: Dosage, Protocol, Reconstitution, and Fat Loss Guide
Tesamorelin Peptide
Tesamorelin is a synthetic GHRH analog that stimulates natural growth hormone release, increasing IGF-1 levels and promoting fat loss—particularly visceral fat. It is FDA-approved for HIV-associated lipodystrophy and widely studied for metabolic and body composition improvements.
How Tesamorelin Works
GHRH → Growth Hormone ↑ → IGF-1 ↑ → Lipolysis ↑ → Visceral Fat ↓
Tesamorelin stimulates the pituitary to release growth hormone in a natural pulsatile rhythm. This increases IGF-1, enhancing fat metabolism while preserving lean mass and avoiding suppression of endogenous GH production.
Tesamorelin Protocol
Week 1
Dose1 mg (1000 mcg)
Units30 units (0.30 mL)
Weeks 2+
Dose2 mg (2000 mcg)
Units60 units (0.60 mL)
Frequency: Once daily
Timing: Evening (aligns with GH pulse)
Cycle Length: 12–26 weeks (up to 52 weeks clinically)
Dosing Notes
- Start at 1 mg to assess tolerance
- Increase to 2 mg for full effect
- Evening dosing improves GH synchronization
- Longer cycles produce better fat loss outcomes
When & Where to Inject
- Inject subcutaneously in the abdomen
- Avoid area within 2 inches of navel
- Rotate injection sites daily
- Inject at consistent time each evening
Reconstitution & Dosing (10 mg Vial)
Vial
10 mg
Water
3.0 mL bacteriostatic
Concentration
3.33 mg/mL
Conversion
1 unit = 33.3 mcg
Reconstitution Steps
Draw 3.0 mL bacteriostatic water
Inject slowly down vial wall
Gently swirl (do not shake)
Ensure solution is clear
Refrigerate immediately
Storage
Lyophilized: 2–8°C (35–46°F)
Reconstituted: 2–8°C (36–46°F)
Do not freeze after mixing
Use Window
Use within 7 days after reconstitution
Monitoring During Use
- IGF-1 levels (key biomarker)
- Body composition (visceral fat reduction)
- Blood glucose / HbA1c
- Lipid profile
- Fluid retention or joint discomfort
Benefits
- Reduces visceral abdominal fat
- Increases natural growth hormone levels
- Improves IGF-1 signaling
- Supports metabolic health
- May reduce liver fat (NAFLD support)
- Preserves lean muscle mass
Potential Side Effects
- Injection site irritation
- Water retention
- Joint stiffness or discomfort
- Mild increase in blood glucose
- Carpal tunnel–like symptoms (rare)
Stacking Strategies
- Fat Loss: Tesamorelin + GLP-1 (Tirzepatide / Semaglutide)
- Advanced: Tesamorelin + Ipamorelin
- Metabolic: Tesamorelin + NAD+
Important Disclaimer
Tesamorelin is FDA-approved for specific medical use but should only be used under medical supervision. This content is for educational purposes only.
Peptide Directory →
Comments
Post a Comment